English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    • SMC Global Securities Limited
    • SBI Life
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    Budget 2023
    Budget 2023
    you are here: HomeNewsBusinessCompanies

    Alembic Pharma gets USFDA nod for generic drug

    The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of diclofenac sodium topical solution is for strength of 2 per cent, the company said in a statement.

    PTI
    December 01, 2022 / 02:10 PM IST
     
     
    live
    • bselive
    • nselive
    Volume
    Todays L/H
    More

    Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic version of diclofenac sodium topical solution indicated to treat pain of osteoarthritis of the knee.

    The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of diclofenac sodium topical solution is for strength of 2 per cent, the company said in a statement.

    "The ANDA was filed by Aleor Dermaceuticals (Aleor), which was amalgamated with Alembic," it added. Aleor had previously received a tentative approval for this ANDA.

    The approved ANDA is therapeutically equivalent to the reference listed drug product Pennsaid topical solution, 2 per cent of Horizon Therapeutics Ireland DAC (Horizon), Alembic said.